Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction

BACKGROUND: Sugammadex, a γ-cyclodextrin derivative, belongs to a new class of selective relaxant binding agents. Sugammadex was approved 10-years ago by the European medicines agency and today is used in clinical anesthesia and emergency medicine globally. In this review, indications for neuromuscu...

Full description

Saved in:
Bibliographic Details
Published in:BMC Anesthesiol
Main Authors: de Boer, Hans D, Carlos, Ricardo V, Brull, Sorin J
Format: Artigo
Language:Inglês
Published: BioMed Central 2018
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6220468/
https://ncbi.nlm.nih.gov/pubmed/30400850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12871-018-0605-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items